*Antisense research and development

LDR 01449nas a2200301 a 4500
001     itacnp85066
003     IT-ACNP
005     20241115070000.0
007     ta
008     940708 19911995usaq  p             engta
022    _a1050-5261
024 7  _aPT00085066
       _2CNR
024 7  _aitacnp85066
       _2IT-ACNP
035    _a(ISSN)1050-5261
040    _atemp
044    _ausa
       _cUSA
082    _a574.87/328
082    _aNULL
222  0 _aAntisense research and development
245 00 _aAntisense research and development
260    _aNew York
       _bMary Ann Liebert
264  2 _cData export is allowed to ACNP participating libraries for institutional purposes and to individuals for personal, non-commercial uses only. Please contact the Bologna University ACNP Team ( acnp.sba.unibo.it/chi-siamo/staff-acnp ) to request permission to use exported data outside the scope of the above license, including but not limited to republication to a group or republishing the website or parts of the website.
264  4 _bUniversità di Bologna
       _ccopyright2024
541    _aissn
       _e1168544
785 10 _tAntisense & nucleic acid drug development
       _w926555
       _x1087-2906
776 1  _tAntisense research and development
       _w2853078
856 40 _aacnp.unibo.it
       _nACNP Italian Union Catalogue of Serials
       _uhttps://acnpsearch.unibo.it/journal/85066
856 40 _aacnp.sba.unibo.it/
       _nARPAC Area Patrimonio Culturale - Università di Bologna
       _macnp.support@unibo.it
       _uhttps://acnp.sba.unibo.it